The transcarotid artery revascularization (TCAR) system builds upon the company’s previous EnRoute system, launched just last month. It delivers smoother arterial sheath insertion, greater flow precision and a simplified prep experience for surgical teams. The system delivers all this while maintaining strong neuroprotection capabilities during the TCAR procedure.
TCAR combines direct carotid artery access with robust blood flow reversal. It provides neuroprotection akin to open surgical techniques in a less invasive, more patient-friendly approach.
During TCAR, the surgical team inserts a tube-like sheath into the carotid artery, connecting it to the EnRoute NPS. This temporarily reverses blood flow as the system filters potentially dangerous debris from the blood. It reduces intraprocedural stroke risk while the team uses a TCAR-specific balloon and stent to open the artery and contain the carotid artery disease.
“With the launch of the NPS PLUS, we’re thrilled to empower our TCAR-trained physicians with a solution that addresses their insights and feedback to further strengthen and streamline the TCAR procedure,” said Chas McKhann, CEO of Silk Road Medical. “Our focus on new product innovation reflects our ongoing commitment to leadership in the treatment of carotid disease.”